Work

Pretherapy quantitative measurement of circulating Epstein–Barr virus DNA is predictive of posttherapy distant failure in patients with early‐stage nasopharyngeal carcinoma of undifferentiated type

FWCI: 6.018
Cites: 12
Cited by: 161
Related to: 10